Results 1 to 10 of about 460 (120)

Evaluation of the anticancer activity of dipyridamole and Imatinib mesylate compounds against breast cancer cell line and related biochemical and genetic changes [PDF]

Journal of Bioscience and Applied Research, 2021
Imatinib mesylate and dipyridamole were antineoplastic targeted chemotherapeutic agents, and it is here evaluating the anticancer of imatinib mesylate and dipyridamole compounds against MDA-MB231 breast cancer cell line in-vitro and the related cell ...
Rania El-Leithy, Aly Mohamed, Asmaa EL-refaay, Mohamed Omran   +3 more
doaj   +1 more source

Effects of dipyridamole and its use in neurology

Медицинский совет, 2021
Dipyridamole has been on the pharmaceutical market since 1959 and, as a pyrimidyl-pyrimidine compound, has a variety of mechanisms of action. The very first action of dipyridamole was its antianginal effect.
N. V. Pizova
doaj   +1 more source

High Grade AV Block Associated with Dipyridamole Infusion

Case Reports in Clinical Practice, 2023
The use of dipyridamole for thallium imaging has proved very successful in demonstrating coronary arterial disease [1]. Dipyridamole causes coronary arteriolar vasodilation by increasing interstitial adenosine levels by inhibition of both adenosine ...
Mahdi Khalili, Mahboubeh Sadat Hoseini, Fatemeh Bayat, Mehrdad Jahani   +3 more
doaj   +1 more source

Dipyridamole activates adenosine A2B receptor and AMPK/cAMP signaling and promotes myogenic differentiation of myoblastic C2C12 cells

Frontiers in Pharmacology, 2023
Introduction: Sarcopenia is defined as a loss of muscle mass and strength. ATP homeostasis is crucial during myogenesis. We determined how the purinergic system modulates myogenesis using dipyridamole (blocks adenosine taken up by the cells) and ...
Miguel Marco-Bonilla, Raquel Herencia, María Fresnadillo, Fernando Huete-Toral, Gonzalo Carracedo, Gonzalo Carracedo, Raquel Largo, Gabriel Herrero-Beaumont, Aránzazu Mediero   +8 more
doaj   +1 more source

Effect of Dipyridamole Injected for Myocardial Perfusion Imaging on Blood Glucose Concentration; A Preliminary Study [PDF]

Journal of Clinical and Diagnostic Research, 2016
Introduction: Dipyridamole inhibits adenosine reuptake and increases cyclic Adenosine Monophosphate (cAMP) levels in platelets, erythrocytes and endothelial cells, all of which influence blood glucose.
Amirreza Khorasanchi, Mohsen Arabi, Alireza Akhavein, Mohammad Seyedabadi, Mansooreh Eftekhari, Hamid Javadi, Iraj Nabipour, Majid Assadi   +7 more
doaj   +1 more source

Spectroscopic and Fluorometric Determination of Cinnarizine and Dipyridamole in Pharmaceutical Tablets Using Eosin Y Dye [PDF]

مجلة التربية والعلم, 2013
Spectrophotometric and spectrofluorimetric methods were developed for the determination of cinnarizine and dipyridamole. The spectrophotometric method is based on the formation of ion pair complex  between the studied drugs and eosin Y which shows ...
Zeina Al - Abdali, Elham Saleh
doaj   +1 more source

The Dipyridamole Added to Dual Antiplatelet Therapy in Cerebral Infarction After First Acute Myocardial Infarction: A Nationwide, Case-Control Study

Frontiers in Neurology, 2018
Background and Purpose: No previous study has compared the impact of dipyridamole-based triple antiplatelet therapy on secondary stroke prevention and long-term outcomes to that of dual antiplatelet therapy (DAPT) in patients with acute myocardial ...
Mei-Tzu Wang, Cheng Ken Tsai, Cheng Ken Tsai, Shu-Hung Kuo, Wei-Chun Huang, Wei-Chun Huang, Wei-Chun Huang, Wei-Chun Huang, Wei-Chun Huang, Kun-Chang Lin, Wang-Ting Hung, Chin-Chang Cheng, Chin-Chang Cheng, Chin-Chang Cheng, Pei-Ling Tang, Cheng Chung Hung, Jin-Shiou Yang, Hsin-Li Liang, Guang-Yuan Mar, Chun-Peng Liu, Chun-Peng Liu   +20 more
doaj   +1 more source

Early antithrombotic post-discharge therapy using prophylactic DOAC or dipyridamole improves long-term survival and cardiovascular outcomes in hospitalized COVID-19 survivors

Frontiers in Cardiovascular Medicine, 2022
IntroductionCardiovascular events are common in COVID-19. While the use of anticoagulation during hospitalization has been established in current guidelines, recommendations regarding antithrombotic therapy in the post-discharge period are conflicting ...
Lukas J. Motloch, Peter Jirak, Moritz Mirna, Lukas Fiedler, Lukas Fiedler, Paruir A. Davtyan, Irina A. Lakman, Irina A. Lakman, Diana F. Gareeva, Anton V. Tyurin, Ruslan M. Gumerov, Simon T. Matskeplishvili, Valentin N. Pavlov, Benzhi Cai, Kristen Kopp, Albert Topf, Uta C. Hoppe, Rudin Pistulli, Naufal S. Zagidullin   +18 more
doaj   +1 more source

Cyclic AMP‐hydrolyzing phosphodiesterase inhibitors potentiate statin‐induced cancer cell death

Molecular Oncology, 2020
Dipyridamole, an antiplatelet drug, has been shown to synergize with statins to induce cancer cell‐specific apoptosis. However, given the polypharmacology of dipyridamole, the mechanism by which it potentiates statin‐induced apoptosis remains unclear ...
Joseph Longo, Aleksandra A. Pandyra, Paweł Stachura, Mark D. Minden, Aaron D. Schimmer, Linda Z. Penn   +5 more
doaj   +1 more source

Dipyridamole treatment is associated with improved renal outcome and patient survival in advanced chronic kidney disease

Kaohsiung Journal of Medical Sciences, 2014
Dipyridamole has been shown to decrease proteinuria and improve renal function progression especially in early chronic kidney disease (CKD) patients with glomerulonephropathy.
Chi-Chih Hung, Mei-Li Yang, Ming-Yen Lin, Hugo You-Hsien Lin, Lee-Moay Lim, Hung-Tien Kuo, Shang-Jyh Hwang, Jer-Chia Tsai, Hung-Chun Chen   +8 more
doaj   +1 more source